Lea M A
J Natl Cancer Inst. 1983 Nov;71(5):1073-6.
The effects of colchicine on the incorporation of [3H]-leucine and [3H]thymidine were studied in inbred BUF rats bearing Morris hepatomas and in isolated hepatoma cells and hepatocytes. The results confirmed previous work by other investigators that uptake of amino acids in hepatomas can be inhibited by colchicine (250 micrograms/100 body wt) under conditions in which uptake is not impeded in host liver. Uptake and incorporation of [3H]thymidine in hepatomas were also more sensitive to inhibition by colchicine. Evidence was obtained that these inhibitory effects on incorporation were diminished in isolated cells and were similar for isolated hepatoma cells and hepatocytes. The data did not exclude alternative mechanisms, but they were compatible with a previous suggestion that an effect of colchicine on circulation in hepatomas may be a factor in the inhibitory action on metabolite uptake.
在患有莫里斯肝癌的近交BUF大鼠以及分离出的肝癌细胞和肝细胞中,研究了秋水仙碱对[3H]-亮氨酸和[3H]胸腺嘧啶掺入的影响。结果证实了其他研究者之前的工作,即在宿主肝脏摄取不受阻碍的条件下,秋水仙碱(250微克/100体重)可抑制肝癌中氨基酸的摄取。肝癌中[3H]胸腺嘧啶的摄取和掺入对秋水仙碱的抑制也更敏感。有证据表明,这些对掺入的抑制作用在分离的细胞中减弱,并且分离的肝癌细胞和肝细胞的情况相似。数据并未排除其他机制,但与之前的一种观点相符,即秋水仙碱对肝癌循环的影响可能是其对代谢物摄取产生抑制作用的一个因素。